การจำแนกชนิดของ Malignanant Lymphoma ทางโลหิตพยาธิวิทยา
Keywords:
-Abstract
-
Downloads
References
Virchow RIK. Die cellulare Pathologie in ihrer Begruendung auf physiologische und pathologische Gewebelehre. Berlin:Hirschwald, 1858.
Virchow RLK. Die Krankhaftern Geschweielste. Berlin: Hirschwald 1863;2:728-38.
Billroth T. Multiple Lymphoma : Erfolgreiche Behand-lung mit Arsenik. Wien Med Wochenschr 1871;21:1066-7.
Willis RA. The tumours of lymphoid tissue. In : Pathology of tumors. St. Louis : Mosby, 1948:760.
Swerdlow SH, Sukpanichnant S, Glick A, Collins RD. Reactive states in lymph nodes resembling lymphomas or progressing to lymphomas. A selective review. Mod Pathol 1993;6:378-91.
Dorfman RF, Warnke R. Lymphadenopathy simulating the malignant lymphomas. Hum Pathol 1974;5:519-50.
Warnke RA, Weiss L.M, Chan JKC, Cleary ML, Dorfman RF. Tumors of the lymph nodes and Spleen. Washington, D.C:Armed Forces Institute of Pathology 1995:435-526.
สัญญา สุขพณิชนันท์. New techniques in hematolology diagnosis: immunophenotypic study in pathology ใน: ธานินทร์ อินทรกำธรชัย (บรรณาธิการ). โลหิตวิทยาก้าวหน้า 1998, กรุงเทพ สมาคมโลหิตวิทยาแห่งประเทศไทย, 2541.69-69-80.
Haluska FG, Brufsky AM, Canellos GP. The cellular biology of the Reed-Sternberg cell. Blood 1994; 84:1005-19.
Lukes RJ, Craver LF, Hall TC, Rapport H, Rubin T. Report of the nomenclature committe. Cancer Res 1966;26:1311.
Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin's disease. Cancer Res 1966; 26:1063-83.
Piankijagum A, Pacharee P, Wasi P. Malignant lymphomas in Thailand: an analysis of 1,095 cases. J Med Assoc Thailand 1980;63:181-91. .
Sukpanichnant S, Sonakul D, Piankijagum A, et al. Malignant lymphoma in Thailand. The changing status from a histopathologic and immunophenotypic analysis of 425 Cases at Siraj Hospital. Cancer (in press).
Gall EA, Mallory TB. Malignant lymphoma: a clinic-opathologic survey of 618 cases. Am J Pathol 1942;18:381-429.
Rappaport H. Tumors of the hematopoietic system. Washington, D.C.Armed Forces Institute of Pathology, 1966.
Dorfman RF. The non-Hodgkin's lymphomas. In: Rebuck J, Berard CW, Abell MR, eds. The reticulo-endothelial system. Baltimore:Williams & Wikins, 1975:262-81.
Nathwani BN, Kim H, Rappaport H. Malignant lymphoma, lymphoblastic. Cancer 1976:38:964-83.
Lukes RJ, Collins RD. Immunological characterization of human malignant lymphomas. Cancer 1974;34 (4 Suppl):1488-503.
Gerard-Marchant R, Hamlin I, Lennert K, Rilke F, Stansfeld AG, Van Unnik JAM. Classification of non-Hodgkin's lymphomas. Lancet 1974;2:406-8.
Stansfeld AG, Diebold J, Kapanci Y, et al. Updated Kiel classification [Letter]. Lancet 1988;1:292-3.
Bennett MH, Farrer-Brown G, Henry K, Jelliffe AM. Classification of non-Hodgkin's lymphoma 1974;2:405-6.
Mathe G, Rappaport H, O' Conor GT, Torloni H. Histological and cytological typing of neoplastic diseases of haematopoietic and lymphoid tissues. International Histological Classification of Tumors, No.14. Geneva:World Health Organization, 1976.
Taylor RC. Classification of lymphoma: new thinking on old thoughts. Arch Pathol Lab Med 1978; 102:549-54.
The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas, summary and description of a Working Formulation for clinical usage. Cancer 1982;49:2112-35.
ประเสริฐ ปาจรีย์. การแบ่งชนิดของลิย์มโฟม่าชนิดร้ายทางจุลกายวิภาค. อายุรศาสตร์ 2529; 2:42-6
Harris NL. Lymphoma 1987: an interim approach to diagnosis and classification. Pathol Annu 1987:1-67.
Harris NL, Jaffe ES, Stein H, et al. A revised European-American Classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92
Chan JKC, Banks PM, Cleary MI, et al. A proposal for classification of lymphoid neoplasms (by the International Lymphoma Study Group). Histopathology 1994;25:517-36.
Chan JKC, Banks PM, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms proposed by the International Lymphoma Study Group. A summary version. Am J Clin Pathol 1995;103:543-60.
Dorfman DM, Shahsafaei A. Usefulness of a new CD5 antibody for the diagnosis of T cell and B cell lymphoproliferative disorders in paraffin sections. Mod Pathol 1997;10:859-63.
Pittaluga S, Bijnens L, Teodorovic I, et al. Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the Working Formulation. Blood 1996;87:4358-67.
Mochen C, Giardini R, Costa A, Silvestrini R. MIB-1 and S-phase cell fraction predict survival in non-Hodgkin's lymphomas. Cell Prolif 1997;30:37-47.
Miller T, Grogan TM, Dahlberg S, et al. Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial. Blood 1994;83:1460-6.
Harris NL, Jaffe ES, Stein H, et al. Lymphoma classification proposal: clarification (correspondence). Blood 1995;85:857-60.
Sheibani K, Nathwani BN, Swartz WG, et al. Variability in interpretation of immunohistologic findings in lymphoproliferative disorders by hematopathologists. A comprehensive statistical analysis of interobserver performance. Cancer 1988,62:657-64.
Liu SY, Press OW. The potential for immunoccconjugates in lymphoma therapy. Hematol/Oncol Clin N America 1997;11:987-1006.
Weisenburger DD, Armitage JO. Mantle cell lymphoma- an entity comes of age. Blood 1996;87:4483-94.
Wootherspoon A, Doglioni C, Diss T, et al. Regression of primary low-grade B cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-7.
de Bruin PC, Noorduyn AL, van der Valk P, et al. Noncutaneous T cell lymphomas. Recognition of a lymphoma type (large cell anaplastic) with a relatively favorable prognosis. Cancer 1993;71:2604-12.
Beljaards RC, Meijer CJLM, Scheffer E, et al. Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T cell origin. A clinicopathologic and immunohistochemical study in 20 patients. Am J Pathol 1989;135:1169-78.
Noorduyn LA, de Bruin PC, van Heerde P, van de Sandt MM, Ossenkoppele GJ, Meijer CJLM. Relation of CD30 expression to survival and morphology in large cell B cell ymphomas. J Clin Pathol 1994,47:33-7.
Intragumtornchai T, Wannakrairoj P, Chaimongkol B, et al. Non-Hodgkin's lymphomas in Thailand. A retrospective pathologic and clinical analysis of 1391 cases. Cancer 1996;78:1813-9.
Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997;90:354-71.
Lukes RJ, Collins RD. Tumors of the hematopoietic system. Washington, D.C.:Armed Forces Institute of Pathology, 1992.
Lennert K, Feller AC. Histopathology of non-Hodgkin's lymphomas (based on the updated Kiel classification). Berlin:Springer-Verlag, 1992.
Hiddemann W, Longo DL, Coiffier B, et al. Lymphoma classification - the gap between biology and cinical management is closing. Blood 1996;88:4085-9.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
